Credit Suisse Downgrades Omnicare (OCR) to Neutral Following Surge on Takeover Speculation
Tweet Send to a Friend
Credit Suisse downgraded Omnicare (NYSE: OCR) from Outperform to Neutral with a price target of $91.00 (from $85.00), after share ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
